Literature DB >> 10215618

Sequence analysis of heparan sulphate and heparin oligosaccharides.

R R Vivès1, D A Pye, M Salmivirta, J J Hopwood, U Lindahl, J T Gallagher.   

Abstract

The biological activity of heparan sulphate (HS) and heparin largely depends on internal oligosaccharide sequences that provide specific binding sites for an extensive range of proteins. Identification of such structures is crucial for the complete understanding of glycosaminoglycan (GAG)-protein interactions. We describe here a simple method of sequence analysis relying on the specific tagging of the sugar reducing end by 3H radiolabelling, the combination of chemical scission and specific enzymic digestion to generate intermediate fragments, and the analysis of the generated products by strong-anion-exchange HPLC. We present full sequence data on microgram quantities of four unknown oligosaccharides (three HS-derived hexasaccharides and one heparin-derived octasaccharide) which illustrate the utility and relative simplicity of the technique. The results clearly show that it is also possible to read sequences of inhomogeneous preparations. Application of this technique to biologically active oligosaccharides should accelerate progress in the understanding of HS and heparin structure-function relationships and provide new insights into the primary structure of these polysaccharides.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10215618      PMCID: PMC1220215     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

Review 1.  Glycosaminoglycans and the regulation of blood coagulation.

Authors:  M C Bourin; U Lindahl
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

2.  Domain structure of heparan sulfates from bovine organs.

Authors:  M Maccarana; Y Sakura; A Tawada; K Yoshida; U Lindahl
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

3.  Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors.

Authors:  S Tessler; P Rockwell; D Hicklin; T Cohen; B Z Levi; L Witte; I R Lemischka; G Neufeld
Journal:  J Biol Chem       Date:  1994-04-29       Impact factor: 5.157

4.  Recombinant alpha-L-iduronidase: characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts.

Authors:  E G Unger; J Durrant; D S Anson; J J Hopwood
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

5.  Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor.

Authors:  M Maccarana; B Casu; U Lindahl
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

Review 6.  Heparan sulfate: a piece of information.

Authors:  M Salmivirta; K Lidholt; U Lindahl
Journal:  FASEB J       Date:  1996-09       Impact factor: 5.191

7.  Liver heparan sulfate structure. A novel molecular design.

Authors:  M Lyon; J A Deakin; J T Gallagher
Journal:  J Biol Chem       Date:  1994-04-15       Impact factor: 5.157

8.  Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants.

Authors:  M Lyon; J A Deakin; K Mizuno; T Nakamura; J T Gallagher
Journal:  J Biol Chem       Date:  1994-04-15       Impact factor: 5.157

9.  Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2.

Authors:  M Ishihara
Journal:  Glycobiology       Date:  1994-12       Impact factor: 4.313

10.  Characterisation by LSI-MS and 1H NMR spectroscopy of tetra-, hexa-, and octa-saccharides of porcine intestinal heparin.

Authors:  W Chai; E F Hounsell; C J Bauer; A M Lawson
Journal:  Carbohydr Res       Date:  1995-04-03       Impact factor: 2.104

View more
  15 in total

1.  Heparin sequencing brings structure to the function of complex oligosaccharides.

Authors:  M A Nugent
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

2.  A computational approach for deciphering the organization of glycosaminoglycans.

Authors:  Jean L Spencer; Joel A Bernanke; Jo Ann Buczek-Thomas; Matthew A Nugent
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

3.  Fibroblast growth factors share binding sites in heparan sulphate.

Authors:  Johan Kreuger; Per Jemth; Emil Sanders-Lindberg; Liat Eliahu; Dina Ron; Claudio Basilico; Markku Salmivirta; Ulf Lindahl
Journal:  Biochem J       Date:  2005-07-01       Impact factor: 3.857

Review 4.  Proteoglycans: pericellular and cell surface multireceptors that integrate external stimuli in the mammary gland.

Authors:  M Delehedde; M Lyon; N Sergeant; H Rahmoune; D G Fernig
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.673

5.  'Heparin'--from anticoagulant drug into the new biology.

Authors:  U Lindahl
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

Review 6.  Hyphenated techniques for the analysis of heparin and heparan sulfate.

Authors:  Bo Yang; Kemal Solakyildirim; Yuqing Chang; Robert J Linhardt
Journal:  Anal Bioanal Chem       Date:  2010-09-19       Impact factor: 4.142

7.  Diversity in tissue expression, substrate binding, and SCF complex formation for a lectin family of ubiquitin ligases.

Authors:  Kevin A Glenn; Rick F Nelson; Hsiang M Wen; Adam J Mallinger; Henry L Paulson
Journal:  J Biol Chem       Date:  2008-01-18       Impact factor: 5.157

Review 8.  Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans.

Authors:  Catherine Kirn-Safran; Mary C Farach-Carson; Daniel D Carson
Journal:  Cell Mol Life Sci       Date:  2009-07-24       Impact factor: 9.261

9.  Heparan sulfate separation, sequencing, and isomeric differentiation: ion mobility spectrometry reveals specific iduronic and glucuronic acid-containing hexasaccharides.

Authors:  Matthew R Schenauer; John K Meissen; Youjin Seo; James B Ames; Julie A Leary
Journal:  Anal Chem       Date:  2009-12-15       Impact factor: 6.986

10.  Novel products in hyaluronan digested by bovine testicular hyaluronidase.

Authors:  Fengchao Chen; Ikuko Kakizaki; Masanori Yamaguchi; Kaoru Kojima; Keiichi Takagaki; Masahiko Endo
Journal:  Glycoconj J       Date:  2008-11-15       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.